Wisløff, T., Hagen, G., & Klemp, M. (2014). Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation. Springer International Publishing.
Styl ChicagoWisløff, Torbjørn, Gunhild Hagen, a Marianne Klemp. Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation. Springer International Publishing, 2014.
Citace podle MLAWisløff, Torbjørn, Gunhild Hagen, a Marianne Klemp. Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation. Springer International Publishing, 2014.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..